Godavari Biorefineries Limited (GODAVARIB)
Analysts/Institutional Investor Meet/Con. Call Updates
AI summary
- Q2 FY27 revenue 549.2 Cr +27.5% y-y; EBITDA 10.9 Cr vs loss 4.4 Cr; PAT loss narrowed to 15.2 Cr
- Bio-based chemicals Q2 revenue 204.2 Cr +38.8%, EBITDA 22.1 Cr +47%, margin 10.8% vs 10.2%
- H1 FY27 total income 1109.7 Cr +14.6%, EBITDA 13.4 Cr vs 2.1 Cr; bio-chemicals EBITDA 41.2 Cr +50%
- Integrated sugar, ethanol, cogeneration segment impacted by feedstock, drought; ethanol capacity 800 kL/day multi-feedstock
- Innovation: European, Chinese, US patents for anti-cancer, antiviral compounds; drug trials to start post regulatory approval
- Capex Rs 25 Cr for bio-chemicals debottlenecking; target Q3 FY28 revenue 240 Cr in bio-chemicals
- Seasonal business: Q3/Q4 expected profitable for sugar/ethanol; grain-based ethanol facility commissioned Q1 FY27
- Multiple analyst queries on bio-chemicals growth drivers, feedstock flexibility, drug discovery progress
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 GODAVARIB — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add GODAVARIB to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Godavari Biorefineries Limited
Important.
The summary above is generated automatically from Godavari Biorefineries Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.